Skip to main content

Table 1 Demographic and clinical-pathologic characteristics of study cohorts

From: A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort

  Bladder cancer
(n = 211)
control
(n = 67)
Median age (range, years) 75 (22–95) 70 (30–90)
Male:female ratio 183/28 53/14
Stage   n/a 
 NMIBC 170 (80.6 %)  
 MIBC 41 (19.4 %)  
Grade   n/a 
 Low 87 (41.2 %)  
 High 124 (58.8 %)  
Clinical stage   n/a 
 Tis high-grade 7 (3.3 %)  
 Ta low-grade 80 (37.9 %)  
 Ta high-grade 29 (13.7 %)  
 T1 low-grade 7 (3.3 %)  
 T1 high-grade 47 (22.3 %)  
 ≥T2 high-grade 41 (19.4 %)